Protonix, Pantoprazole News

Therefore, such patients are expected to benefit from profound acid suppression.

The present disclosure relates to a process for the preparation of lansoprazole with desired particle-size in high yield and purity with appropriate particle-size distribution.

Santarus, Inc. , a specialty pharmaceutical company, today announced the presentation of an abstract at the Digestive Disease Week annual meeting of positive pharmacodynamic study results indicating that, after ... via Earth Times

“World over, the chemical API production is under increasing cost pressures. We will focus on the pharmaceutical production, because this is an area for future innovation where we can utilise all our know-how to compete.”

Zydus Nycomed, the 50:50 joint venture company set up by Zydus Cadila and Nycomed, will now take up chemical production of active pharmaceutical ingredients . via India Gazette

Type in a key word to find a product: e.g. coffee, t-shirt, shrimp. Tip: click on any appropriate section, e.g. "Sell", then type in a keyword to locate that product or a company in selected section. via VietnamTrade.org

A Viewer Asks: I am wondering if exercise will help with a hiatal hernia? I am also curious if alcohol or tobacco has any effects on Protonix? Dr. via MedicineNet

Medication Update alerts readers to new drug approvals and other timely drug information. via Nursing Center

Generic drug maker Teva Pharmaceutical Industries Ltd. said Tuesday profit rose 24 percent in the fourth quarter, as the launch of generic Protonix helped drive revenue growth. via Canadian Business Magazine

Seamus Fernandez - Leerink Swann Michael Krensavage - Raymond James Catherine Arnold - Credit Suisse Scott Braunstein - J.P. Morgan Michael Castor - SIO Capital Tim Anderson - Sanford Bernstein Presentation ... via Seeking Alpha

Feb 1, 2008 - Teva Pharmaceutical Industries Ltd. announced today following their press release dated January 29, 2008, that the Company has not relaunched and does not intend to ship additional units of ... via Med Ad News

“Our customers count on Teva for a continuous supply of new generic products”

NORTH WALES, Pa., January 31, 2008 Teva Pharmaceuticals is pleased to announce the introduction and availability of Pantoprazole Sodium Delayed-Release Tablets. via Med Ad News

“But growth resumes in 2011 and should persist annually for many years thereafter.”

Wyeth's earnings jumped 17 percent in last year's fourth quarter and rose nearly 10 percent for all of 2007, the company said today. via Philly.com

A distribution agreement between Prasco Laboratories and a division of Wyeth Pharmaceuticals will allow the Cincinnati-based company to market a generic version of the acid reflux drug Protonix being launched ... via Cincinnati Business Courier

Mumbai : Pharmaceutical firm Sun Pharma on Wednesday said it has commercially launched Pantoprazole tablets in the United States, used for treating oesophagus ailments. via The Hindu

“We believe the Protonix compound patent is strong and we will vigorously pursue our litigation against Teva and other infringing generics”

Wyeth said on Tuesday it had launched a U.S. generic form of its blockbuster Protonix heartburn drug, even as it continues legal action to stop other companies from selling their own generic forms of the ... via Reuters

Wyeth Pharmaceuticals, a division of Wyeth , announced today that it has agreed with Teva Pharmaceuticals USA, Inc. via The South Mississippi Sun Herald

“In addition to the advantage of immediate-release ZEGERID's rapid absorption, we saw a difference in the duration of acid control with chronic morning dosing as measured on day seven of the trial.”

Martha L. Hough, VP Finance & Investor Relations 858-314-5824 or Debra P. Crawford, Chief Financial Officer 858-314-5708 or Investor Contact: Lippert/Heilshorn & Associates, Inc. via PR-inside.com

“In addition to the advantage of immediate-release ZEGERID's rapid absorption, we saw a difference in the duration of acid control with chronic morning dosing as measured on day seven of the trial.”

Santarus, Inc. , a specialty pharmaceutical company, today announced positive results from a recently completed clinical trial with immediate-release ZEGERID Capsules 40 mg/1100 mg and two leading proton pump ... via Freshnews